Mabpharm Limited's total assets for Q2 2024 were ¥946.39M, a decrease of -8.56% from the previous quarter. HK:2181 total liabilities were ¥831.20M for the fiscal quarter, a 0.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.